{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T20:38:54Z","timestamp":1789331934115,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/jp.2015.126","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T13:01:39Z","timestamp":1445518899000},"page":"137-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Sildenafil and retinopathy of prematurity risk in very low birth weight infants"],"prefix":"10.1038","volume":"36","author":[{"given":"S","family":"Samiee-Zafarghandy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J N","family":"van den Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M M","family":"Laughon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R H","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P B","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C P","family":"Hornik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the Best Pharmaceuticals for Children Act \u2013 Pediatric Trials Network Administrative Core Committee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"issue":"1","key":"BFjp2015126_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s13312-011-0012-2","volume":"48","author":"M Malik","year":"2011","unstructured":"Malik M, Nagpal R . Emerging role of sildenafil in neonatology. Indian Pediatr 2011; 48 (1): 11\u201313.","journal-title":"Indian Pediatr"},{"issue":"4","key":"BFjp2015126_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/PCC.0000000000000077","volume":"15","author":"S Samiee-Zafarghandy","year":"2014","unstructured":"Samiee-Zafarghandy S, Smith PB, van den Anker J . Safety of sildenafil in infants. Pediatr Crit Care Med 2014; 15 (4): 362\u2013368.","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"BFjp2015126_CR3","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1001\/archophthalmol.2009.36","volume":"127","author":"W Cordell","year":"2009","unstructured":"Cordell W . Retinal effects of 6 months of daily use of tadalafil or sildenafil. Arch Ophthalmol 2009; 127 (4): 367.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFjp2015126_CR4","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1111\/j.1743-6109.2011.02382.x","volume":"8","author":"F Azzouni","year":"2011","unstructured":"Azzouni F, Abu Samra K . Are phosphodiesterase type 5 inhibitors associated with vision-threatening adverse events? A critical analysis and review of the literature. J Sex Med 2011; 8 (10): 2894\u20132903.","journal-title":"J Sex Med"},{"issue":"2","key":"BFjp2015126_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1136\/bjo.2003.021956","volume":"88","author":"C Marsh","year":"2004","unstructured":"Marsh C . Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol 2004; 88 (2): 306\u2013307.","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"BFjp2015126_CR6","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1055\/s-0033-1361933","volume":"31","author":"E Hsieh","year":"2013","unstructured":"Hsieh E, Hornik C, Clark R, Laughon M, Benjamin D, Smith PB . Medication use in the neonatal intensive care unit. Am J Perinatol 2013; 31 (9): 811\u2013822.","journal-title":"Am J Perinatol"},{"issue":"2","key":"BFjp2015126_CR7","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.1542\/peds.2009-0913","volume":"125","author":"I Olsen","year":"2010","unstructured":"Olsen I, Groveman S, Lawson M, Clark R, Zemel B . New intrauterine growth curves based on United States data. Pediatrics 2010; 125 (2): e214\u2013e224.","journal-title":"Pediatrics"},{"issue":"1","key":"BFjp2015126_CR8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2307\/2533160","volume":"52","author":"DB Rubin","year":"1996","unstructured":"Rubin DB, Thomas N . Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52 (1): 249\u2013264.","journal-title":"Biometrics"},{"issue":"12","key":"BFjp2015126_CR9","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1093\/aje\/kwj149","volume":"163","author":"MA Brookhart","year":"2006","unstructured":"Brookhart MA, Schneeweiss S, Rothman KJ, Glynn RJ, Avorn J, Sturmer T . Variable selection for propensity score models. Am J Epidemiol 2006; 163 (12): 1149\u20131156.","journal-title":"Am J Epidemiol"},{"key":"BFjp2015126_CR10","unstructured":"Leuven E, Sianesi B . Psmatch2: stata module to perform full Mahalanobis and propensity score matching, common support graphing, and covariate imbalance testing. Available from http:\/\/ideas.repec.org\/c\/boc\/bocode\/s432001.html Created 2003; revised 2015."},{"issue":"3","key":"BFjp2015126_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/jp.2012.84","volume":"33","author":"A Fang","year":"2012","unstructured":"Fang A, Guy K, K\u00f6nig K . The effect of sildenafil on retinopathy of prematurity in very preterm infants. J Perinatol 2012; 33 (3): 218\u2013221.","journal-title":"J Perinatol"},{"issue":"2","key":"BFjp2015126_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jaapos.2009.12.161","volume":"14","author":"R Kehat","year":"2010","unstructured":"Kehat R, Bonsall D, North R, Connors B . Ocular findings of oral sildenafil use in term and near-term neonates. J AAPOS 2010; 14 (2): 159\u2013162.","journal-title":"J AAPOS"},{"issue":"1","key":"BFjp2015126_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00002018-200932010-00001","volume":"32","author":"A Laties","year":"2009","unstructured":"Laties A . Vision disorders and phosphodiesterase type 5 inhibitors. Drug Saf 2009; 32 (1): 1\u201318.","journal-title":"Drug Saf"},{"key":"BFjp2015126_CR14","unstructured":"Center for Drug Evaluation and Research NDA 020895\/S-21 Viagra (Sildenafil Citrate) Tablets: Clinical Pharmacology\/Biopharmaceutics Review. Department of Health and Human Services, US Food and Drug Administration: Rockville, MD, 1998."},{"key":"BFjp2015126_CR15","unstructured":"Center for Drug Evaluation and Research Study 148\u2013223: a double-blind, randomized, placebo-controlled, four-period crossover study to assess the effect of orally administered sildenafil (50, 100, and 200 mg) on visual function in healthy male volunteers. In: Viagra (Sildenafil): Joint Clinical Review for NDA-20-895. Center for Drug Evaluation and Research, FDA: Washington, DC, 1998, pp 160\u2013161."},{"issue":"3","key":"BFjp2015126_CR16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0002-9394(98)00243-8","volume":"126","author":"S Donahue","year":"1998","unstructured":"Donahue S, Taylor R . Pupil-sparing third nerve palsy associated with sildenafil citrate (Viagra). Am J Ophthalmol 1998; 126 (3): 476\u2013477.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"BFjp2015126_CR17","first-page":"291","volume":"118","author":"R Egan","year":"2000","unstructured":"Egan R, Pomeranz H . Sildenafil (Viagra) associated anterior ischemic optic neuropathy. Arch Ophthalmol 2000; 118 (2): 291\u2013292.","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"BFjp2015126_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/00041327-200103000-00006","volume":"21","author":"A Cunningham","year":"2001","unstructured":"Cunningham A, Smith K . Anterior ischemic optic neuropathy associated with Viagra. J Neuroophthalmol 2001; 21 (1): 22\u201325.","journal-title":"J Neuroophthalmol"},{"issue":"1","key":"BFjp2015126_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/sj.eye.6702908","volume":"22","author":"C Foresta","year":"2007","unstructured":"Foresta C, Caretta N, Zuccarello D, Poletti A, Biagioli A, Caretti L et al. Expression of the PDE5 enzyme on human retinal tissue: new aspects of PDE5 inhibitors ocular side effects. Eye 2007; 22 (1): 144\u2013149.","journal-title":"Eye"},{"issue":"1","key":"BFjp2015126_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.exer.2011.05.010","volume":"93","author":"R Gerometta","year":"2011","unstructured":"Gerometta R, Alvarez L, Candia O . Effect of sildenafil citrate on intraocular pressure and blood pressure in human volunteers. Exp Eye Res 2011; 93 (1): 103\u2013107.","journal-title":"Exp Eye Res"},{"issue":"4","key":"BFjp2015126_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1136\/bjo.2007.131789","volume":"92","author":"A Harris","year":"2008","unstructured":"Harris A, Kagemann L, Ehrlich R, Ehrlich Y, Lopez C, Purvin V . The effect of sildenafil on ocular blood flow. Br J Ophthalmol 2008; 92 (4): 469\u2013473.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"BFjp2015126_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/IAE.0b013e3181eef0ae","volume":"31","author":"S Vance","year":"2011","unstructured":"Vance S, Imamura Y, Freund K . The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina 2011; 31 (2): 332\u2013335.","journal-title":"Retina"},{"issue":"1","key":"BFjp2015126_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/aos.12049","volume":"92","author":"G Cavallaro","year":"2013","unstructured":"Cavallaro G, Filippi L, Bagnoli P, La Marca G, Cristofori G, Raffaeli G et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol 2013; 92 (1): 2\u201320.","journal-title":"Acta Ophthalmol"},{"issue":"4","key":"BFjp2015126_CR24","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/sj.ijir.3900537","volume":"12","author":"R Heywood","year":"2000","unstructured":"Heywood R, Osterloh IH, Phillips SC . Sildenafil causes a dose- and time-dependent downregulation of phosphodiesterase type 6 expression in the rat retina. Int J Impot Res 2000; 12 (4): 241\u2013244.","journal-title":"Int J Impot Res"},{"issue":"5A","key":"BFjp2015126_CR25","doi-asserted-by":"publisher","first-page":"13C","DOI":"10.1016\/S0002-9149(99)00043-0","volume":"83","author":"G Jackson","year":"1999","unstructured":"Jackson G, Benjamin N, Jackson N, Allen MJ . Effects of sildenafil citrate on human hemodynamics. Am J Cardiol 1999; 83 (5A): 13C\u201320C.","journal-title":"Am J Cardiol"},{"issue":"7","key":"BFjp2015126_CR26","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archopht.123.7.991","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","unstructured":"International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123 (7): 991\u2013999.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"BFjp2015126_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/sj.eye.6702728","volume":"22","author":"A Misra","year":"2007","unstructured":"Misra A, Heckford E, Curley A, Allen L . Do current retinopathy of prematurity screening guidelines miss the early development of pre-threshold type 1 ROP in small for gestational age neonates? Eye 2007; 22 (6): 825\u2013829.","journal-title":"Eye"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp2015126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2015126","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp2015126.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:00:25Z","timestamp":1744174825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp2015126"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["BFjp2015126"],"URL":"https:\/\/doi.org\/10.1038\/jp.2015.126","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]},"assertion":[{"value":"27 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Smith receives salary support for research from the National Institutes of Health (NIH) and the National Center for Advancing Translational Sciences of the NIH (UL1TR001117), the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (HHSN275201000003I and 1R01-HD081044-01) and the Food and Drug Administration (1R18-FD005292-01); he also receives research support from Cempra Pharmaceuticals (subaward to HHS0100201300009C) and industry for neonatal and pediatric drug development (). Dr van den Anker receives salary support for research from the NIH (5K24DA027992, 5U54HD071601, 5R01HD060543). Dr Hornik receives salary support for research from the National Center for Advancing Translational Sciences of the NIH (UL1TR001117). Dr Laughon receives support from the US government for his work in pediatric and neonatal clinical pharmacology (HHSN267200700051C, PI: Benjamin, under the Best Pharmaceuticals for Children Act) and from the NICHD (5K23HD068497-01). The other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}